• Anthony J. Hickey
  • Stefano Giovagnoli
Part of the AAPS Introductions in the Pharmaceutical Sciences book series (AAPSINSTR)


Crystallization is the physical process of forming a crystalline material from a liquid, gas, or amorphous solid. The control of the crystallization process has several implications in the pharmaceutical field and a strong valence in the determination of API and excipient properties, which impact solid dosage form performance. Lack of control on the dynamics of crystal equilibria is detrimental to manufacturing and stability of pharmaceutical dosage forms. Such an increased awareness has fostered the development of advanced powder technologies.


  1. 1.
    Chen J, Sarma B, Evans JMB, Myerson AS. Pharmaceutical crystallization. Cryst Growth Des. 2011;11(4):887–95.CrossRefGoogle Scholar
  2. 2.
    Cubillas P, Anderson MW. Synthesis mechanism: crystal growth and nucleation. In: Jiři Č, Corma A, Zones S, editors. Zeolites and catalysis [Internet]. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2010. p. 1–55. Available from:
  3. 3.
    Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev. 2007;59(7):617–30.CrossRefPubMedGoogle Scholar
  4. 4.
    Thakuria R, Delori A, Jones W, Lipert MP, Roy L, Rodríguez-Hornedo N. Pharmaceutical cocrystals and poorly soluble drugs. Int J Pharm. 2013;453:101–25.CrossRefPubMedGoogle Scholar
  5. 5.
    Kuminek G, Cao F, Bahia de Oliveira da Rocha A, Gonçalves Cardoso S, Rodríguez-Hornedo N. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5. Adv Drug Deliv Rev. 2016;101:143–66.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Berry DJ, Steed JW. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design. Adv Drug Deliv Rev. 2017;117:3–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Singhal D, Curatolo W. Drug polymorphism and dosage form design: a practical perspective. Adv Drug Deliv Rev. 2004;56:335–47.CrossRefPubMedGoogle Scholar
  8. 8.
    Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59:454–77.CrossRefPubMedGoogle Scholar
  9. 9.
    Jørgensen AC, Strachan CJ, Pöllänen KH, Koradia V, Tian F, Rantanen J. An insight into water of crystallization during processing using vibrational spectroscopy. J Pharm Sci. 2009;98:3903–32.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Anthony J. Hickey
    • 1
  • Stefano Giovagnoli
    • 2
  1. 1.Discovery Science and TechnologyRTI InternationalResearch Triangle ParkUSA
  2. 2.Department of Pharmaceutical SciencesUniversity of PerugiaPerugiaItaly

Personalised recommendations